Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Nuvilex - 22 Year Stock Price History | PMCB

Historical daily share price chart and data for Nuvilex since 2003 adjusted for splits and dividends. The latest closing stock price for Nuvilex as of May 29, 2025 is 1.03.
  • The all-time high Nuvilex stock closing price was 1080.05 on May 13, 2004.
  • The Nuvilex 52-week high stock price is 2.42, which is 135% above the current share price.
  • The Nuvilex 52-week low stock price is 1.00, which is 2.9% below the current share price.
  • The average Nuvilex stock price for the last 52 weeks is 1.67.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Nuvilex Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 1.4290 1.6401 1.8100 1.0102 1.0300 -34.39%
2024 1.9734 2.1850 2.5200 1.4700 1.5700 -27.31%
2023 2.6618 2.9300 3.1800 2.0100 2.1600 -26.28%
2022 2.4524 2.7700 3.0700 1.9100 2.9300 17.20%
2021 14.8461 11.2506 50.4025 2.2800 2.5000 -75.13%
2020 34.9106 61.2031 85.3543 6.3003 10.0505 -83.46%
2019 60.8913 58.7129 93.0047 48.0024 60.7530 9.46%
2018 86.0040 91.5046 147.4570 55.5028 55.5028 -33.69%
2017 112.9108 214.4960 214.4960 49.5025 83.7042 -62.53%
2016 91.1816 84.7542 234.7620 42.7521 223.3610 223.84%
2015 176.8013 288.0140 325.5160 68.9735 68.9735 -74.46%
2014 380.8679 171.7590 765.0380 171.7590 270.0130 76.47%
2013 158.1187 55.5028 308.8660 39.0020 153.0080 176.42%
2012 69.7818 70.5035 106.5050 36.0018 55.3528 -18.90%
2011 65.8985 26.2513 105.0050 19.5010 68.2534 264.00%
2010 19.9340 39.0020 45.0023 9.7505 18.7509 -55.36%
2009 62.3722 52.5026 139.5070 30.1515 42.0021 -26.32%
2008 175.2882 315.0160 345.0170 45.0023 57.0029 -82.65%
2007 468.9670 262.5130 742.5370 247.5120 328.5160 28.82%
2006 381.6177 382.5190 742.5370 240.0120 255.0130 -34.62%
2005 478.9418 630.0310 780.0390 255.0130 390.0200 -38.10%
2004 727.7065 675.0340 1080.0500 375.0190 630.0310 5.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.007B $0.000B
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company. It is focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R). The Company's patented technology is used in the treatment of several types of cancer, including advanced, inoperable pancreatic cancer and diabetes. PharmaCyte Biotech, Inc., formerly known as Nuvilex, Inc., is based in United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.007B 31.89
Zoetis (ZTS) United States $73.637B 27.48
Daiichi Sankyo, - (DSNKY) Japan $51.945B 26.43
Takeda Pharmaceutical (TAK) Japan $46.424B 9.23
Sandoz Group AG (SDZNY) Switzerland $21.498B 0.00
Summit Therapeutics (SMMT) United States $19.339B 0.00
Merck (MKKGY) Germany $16.886B 12.37
United Therapeutics (UTHR) United States $14.237B 12.60
Shionogi (SGIOY) Japan $13.900B 13.93
Neurocrine Biosciences (NBIX) United States $12.176B 41.71
IPSEN (IPSEY) France $9.821B 0.00
Orion OYJ (ORINY) Finland $9.318B 25.20
Corcept Therapeutics (CORT) United States $8.234B 66.94
Stevanato Group S.p.A (STVN) Italy $7.023B 42.94
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.014B 0.00
Grifols, S.A (GRFS) Spain $5.624B 0.00
Ionis Pharmaceuticals (IONS) United States $5.162B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.818B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.993B 10.49
Crinetics Pharmaceuticals (CRNX) United States $2.800B 0.00
Hypermarcas (HYPMY) Brazil $2.707B 17.81
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.260B 12.22
BioCryst Pharmaceuticals (BCRX) United States $2.210B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.943B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.787B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.730B 0.00
Indivior (INDV) United States $1.660B 7.04
ARS Pharmaceuticals (SPRY) United States $1.458B 0.00
Evotec AG (EVO) Germany $1.406B 0.00
Guardian Pharmacy Services (GRDN) United States $1.358B 0.00
Dyne Therapeutics (DYN) United States $1.337B 0.00
Ocular Therapeutix (OCUL) United States $1.257B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.078B 21.57
Harrow (HROW) United States $0.951B 0.00
Ardelyx (ARDX) United States $0.935B 0.00
Collegium Pharmaceutical (COLL) United States $0.929B 5.01
Avadel Pharmaceuticals (AVDL) Ireland $0.875B 0.00
Enliven Therapeutics (ELVN) United States $0.789B 0.00
Cronos Group (CRON) Canada $0.779B 0.00
Akebia Therapeutics (AKBA) United States $0.756B 0.00
Xeris Biopharma Holdings (XERS) United States $0.748B 0.00
AleAnna (ANNA) United States $0.601B 0.00
Elite Pharmaceuticals (ELTP) United States $0.575B 0.00
KalVista Pharmaceuticals (KALV) United States $0.567B 0.00
USANA Health Sciences (USNA) United States $0.553B 12.02
Regulus Therapeutics (RGLS) United States $0.549B 0.00
Xencor (XNCR) United States $0.537B 0.00
Bioventus (BVS) United States $0.536B 13.60
Relay Therapeutics (RLAY) United States $0.506B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.458B 0.00
Zevra Therapeutics (ZVRA) United States $0.455B 0.00
Altimmune (ALT) United States $0.445B 0.00
Siga Technologies (SIGA) United States $0.435B 9.09
Oruka Therapeutics (ORKA) United States $0.429B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.427B 0.00
CytoDyn (CYDY) United States $0.421B 0.00
Tourmaline Bio (TRML) United States $0.402B 0.00
Verve Therapeutics (VERV) United States $0.378B 0.00
Savara (SVRA) United States $0.369B 0.00
Organogenesis (ORGO) United States $0.364B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.343B 9.27
Heron Therapeutics (HRTX) United States $0.279B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.276B 0.00
Aquestive Therapeutics (AQST) United States $0.271B 0.00
Nature's Sunshine Products (NATR) United States $0.269B 24.88
MediWound (MDWD) Israel $0.228B 0.00
ProKidney (PROK) United States $0.207B 0.00
Nanobiotix S.A (NBTX) France $0.189B 0.00
Journey Medical (DERM) United States $0.183B 0.00
Wellgistics Health (WGRX) United States $0.167B 0.00
Esperion Therapeutics (ESPR) United States $0.165B 0.00
Avita Medical (RCEL) United States $0.164B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
4D Molecular Therapeutics (FDMT) United States $0.161B 0.00
OmniAb (OABI) United States $0.158B 0.00
Profound Medical (PROF) Canada $0.157B 0.00
Aclaris Therapeutics (ACRS) United States $0.153B 0.00
Inhibikase Therapeutics (IKT) United States $0.152B 0.00
Aldeyra Therapeutics (ALDX) United States $0.133B 0.00
Nektar Therapeutics (NKTR) United States $0.130B 0.00
Larimar Therapeutics (LRMR) United States $0.127B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.125B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Protara Therapeutics (TARA) United States $0.122B 0.00
Lyell Immunopharma (LYEL) United States $0.121B 0.00
Liminatus Pharma (LIMN) $0.119B 0.00
Korro Bio (KRRO) United States $0.117B 0.00
Achieve Life Sciences (ACHV) Canada $0.109B 0.00
Cardiol Therapeutics (CRDL) Canada $0.106B 0.00
VAXART, INC (VXRT) United States $0.103B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.096B 0.00
Fractyl Health (GUTS) United States $0.093B 0.00
Lexeo Therapeutics (LXEO) United States $0.091B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.088B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 64.89
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Inotiv (NOTV) United States $0.083B 0.00
Champions Oncology (CSBR) United States $0.083B 13.59
Galectin Therapeutics (GALT) United States $0.082B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Unicycive Therapeutics (UNCY) United States $0.074B 0.00
Nutriband (NTRB) United States $0.070B 0.00
Dominari Holdings (DOMH) United States $0.069B 0.00
Surrozen (SRZN) United States $0.068B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.066B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Telomir Pharmaceuticals (TELO) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Context Therapeutics (CNTX) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.052B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.050B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
PMV Pharmaceuticals (PMVP) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
NRx Pharmaceuticals (NRXP) United States $0.045B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Avalo Therapeutics (AVTX) United States $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
SCYNEXIS (SCYX) United States $0.036B 0.00
Acrivon Therapeutics (ACRV) United States $0.034B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Rafael Holdings (RFL) United States $0.032B 0.00
Jupiter Neurosciences (JUNS) United States $0.027B 0.00
PolyPid (PYPD) Israel $0.026B 0.00
Relmada Therapeutics (RLMD) United States $0.024B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
DURECT (DRRX) United States $0.016B 0.00
Ainos (AIMD) United States $0.016B 0.00
SHINECO (SISI) China $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
GlycoMimetics (GLYC) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 1.88
Talphera (TLPH) United States $0.010B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Aditxt (ADTX) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00